What are the highlights of glaucoma prevention and treatment in China in the future?
Journal Title: Eye Science (Yanke Xuebao) - Year 2021, Vol 36, Issue 6
Abstract
Glaucoma is the first irreversible blinding eye disease in the world. How to detect early, diagnose timely, treat appropriately and adhere to follow-up management has always been the direction of Chinese ophthalmic clinical workers. At present, the world is undergoing profound changes, and China is in the best period of development since modern times. In the next 5–10 years, there will be many remarkable achievements in the field of glaucoma prevention and treatment in China. Based on our personal understanding of this specialty, we look forward to the development of glaucoma management in China in the future, and wish to make greater progress in blindness prevention and treatment in China.
Authors and Affiliations
Junyi CHEN, Xinghuai SUN
Keywords
Related Articles
- EP ID EP763517
- DOI 10.3978/j.issn.1000-4432.2021.06.03
- Views 16
- Downloads 0
Clinicopathological analysis of 10 cases of pigment nevus of lacrimal caruncle complicated with squamous cell papilloma
[Objective:] To analyze the clinical pathologic characteristics of pigment nevus of lacrimal caruncle complicated with squamous cell papilloma. [Methods:] This is retrospective case series study including ten patients di...
A case of pseudo plus-minus lid syndrome
A 62-year-old female patient presented with right eye protrusion for 2 years and hypertension for 3 years. Physical examination showed that the upper eyelid retraction of the right eye was about 1.5 mm, and the ptosis of...
Determination of tetracaine hydrochloride and ethyl hydrobenzoate in tetracaine hydrochloride eye drops by HPLC
[Objective:] To establish a high-performance liquid chromatography (HPLC) method for the determination of tetracaine hydrochloride and ethyl hydrobenzoate in tetracaine hydrochloride eye drops. [Methods:] The analytic co...
Management experience of multicenter clinical trial in ophthalmology
Because of the limitation of single-center clinical trials, more researchers attach importance to multicenter clinical trials. Only 6 multicenter clinical trials were registered on Chinese Clinical Trials Registry Center...
Application of artificial intelligence in ocular fundus diseases
Artificial intelligence (AI) is about simulating and expanding human intelligence. AI based on deep learning (DL) can analyze images well by using their inherent features, such as outlines, frames and so on. As researche...